Bionano Genomics, Inc. (BNGO)
1.66
-0.02
(-1.19%)
USD |
NASDAQ |
Dec 11, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Cash from Investing (Quarterly): -4.669M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp. | -23.80M |
| Azenta, Inc. | 0.826M |
| Harvard Bioscience, Inc. | -0.348M |
| Precipio, Inc. | -0.054M |
| Kestra Medical Technologies Ltd. | -8.232M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.919M |
| Cash from Financing (Quarterly) | 10.08M |
| Free Cash Flow | -18.98M |
| Free Cash Flow Per Share (Quarterly) | -1.109 |
| Free Cash Flow to Equity (Quarterly) | -3.535M |
| Free Cash Flow to Firm (Quarterly) | -5.850M |
| Free Cash Flow Yield | -342.8% |